Discover the latest headlines on FoxBusiness.com.
The Food and Drug Administration (FDA) has announced the withdrawal of approximately 90,000 containers of pediatric ibuprofen due to the possible existence of an extraneous material.
As reported by the agency, Strides Pharma, Inc., an Indian-based firm, issued a recall for roughly 89,592 units of its 100-milligram Children’s Ibuprofen Oral Suspension.
This particular item, produced on behalf of Taro Pharmaceuticals USA, was disseminated throughout the United States.
The pain reliever was offered in containers holding 4 fluid ounces, with a concentration of 100 milligrams per 5 milliliters.
BOTANICAL REMEDY DISCOVERED TO HARBOR UNDISCLOSED VIAGRA COMPONENT, FDA ADVISES USERS TO CEASE CONSUMPTION
Approximately 90,000 units of pediatric ibuprofen have been withdrawn.(Getty Images / Getty Images)
The affected batches bore batch identifiers 7261973A and 7261974A, expiring on January 31, 2027.
Initially announced at the beginning of this month, the withdrawal followed reports detailing a gelatinous substance and dark particulates within the item.
GENERAL MOTORS WITHDRAWS 17,000 AUTOMOBILES DUE TO REAR TOE LINK BREAKAGE POTENTIALLY CAUSING ACCIDENTS
This particular item was produced for Taro Pharmaceuticals USA and disseminated throughout the United States.(iStock / iStock)
However, the FDA revised its categorization this week to a Class II withdrawal, signifying that “consumption of or contact with a non-compliant item might result in temporary or medically treatable detrimental health effects, or where the likelihood of severe detrimental health effects is distant.”
This Class II categorization represents the agency’s second-most critical level of urgency.
This Class II categorization represents the FDA’s second-most critical level of urgency.(Stefani Reynolds/Bloomberg via Getty Images / Getty Images)
CLICK HERE TO GET FOX BUSINESS ON THE GO
Individuals who acquired the withdrawn ibuprofen are strongly advised to cease its use without delay.
Guardians harboring worries, should their child have ingested the item, ought to confer with a medical professional.